[Factitious hypoglycemia : "a never-ending story"?]

Ann Biol Clin (Paris). 2018 Aug 1;76(4):439-444. doi: 10.1684/abc.2018.1362.
[Article in French]

Abstract

Our team of diabetologist is challenged by the case of a 41 year-old woman with recurrent hypoglycaemic episodes. Her clinical background was complex with, among others, a neuroendocrine tumor, a nonalcoholic steatohepatitis and an adrenal insufficiency; these conditions require the exploration of several potential causes. After excluding an endogenous etiology, a factitious hypoglycemia was quicky suspected by clinicians. However, several venous samples showed normal insulinemia and a moderately decreased C-peptide. After multidisciplinary team discussion and facing a strong clinical suspicion, samples were sent to another laboratory to confirm the insulin results. Substantially supratherapeutics insulin concentrations were highlighted. This confirms the previous suspicion of surreptitious insulin administration with a recombinant form unrecognized by our routinely used analyzer. This observation leads us to briefly discuss the lack of cross-reactivities observed with many different insulin assays.

Keywords: cross-reactivity; diabetes; hypoglycemia; immunoassay; insulin.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Chemical Analysis / standards
  • Diagnosis, Differential
  • Factitious Disorders / blood
  • Factitious Disorders / diagnosis*
  • Female
  • Humans
  • Hypoglycemia / blood
  • Hypoglycemia / chemically induced*
  • Hypoglycemia / diagnosis*
  • Insulin / adverse effects*
  • Insulin / analysis
  • Insulin / blood

Substances

  • Insulin